Regeneron Pharmaceuticals, Inc. (REGN) Return on Equity (ROE) and Return on Assets (ROA)
Regeneron Pharmaceuticals, Inc. (REGN) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.
ROE & ROA Data
| Period | ROE | ROA |
|---|---|---|
| 2016-12-31 | 20.13% | 12.84% |
| 2017-12-31 | 19.51% | 13.67% |
| 2018-12-31 | 27.91% | 20.83% |
| 2019-12-31 | 18.10% | 14.98% |
| 2020-12-31 | 31.86% | 20.47% |
| 2021-12-31 | 43.03% | 31.75% |
| 2022-12-31 | 19.14% | 14.85% |
| 2023-12-31 | 15.22% | 11.95% |
| 2024-12-31 | 15.03% | 11.69% |
| 2025-12-31 | 14.41% | 11.11% |
Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Return_on_Average_Equity("REGN", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | REGN | $927.89 | +13.33% | 2.85M |
| 3 | ||||
| 4 | ||||
| 5 |